In the supratentorial compartment, there are two other groups with different molecular features, clinical characteristics and outcome, i.e., the supratentorial ependymoma ZFTA fusion-positive and the supratentorial ependymoma YAP1 fusion-positive. This evidence concerns the gene YAP1 and supratentorial ependymoma.